Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 113Urinary Bladder Neoplasms 56Carcinoma, Non-Small-Cell Lung 52Cholangiocarcinoma 33Biliary Tract Neoplasms 32Neoplasm Metastasis 30Ovarian Neoplasms 27Lymphoma, Large B-Cell, Diffuse 26Breast Neoplasms 25Lung Neoplasms 24Neoplasms 23Carcinoma, Transitional Cell 23Triple Negative Breast Neoplasms 22Nasopharyngeal Carcinoma 21Colorectal Neoplasms 20Recurrence 17Non-Muscle Invasive Bladder Neoplasms 16Gallbladder Neoplasms 15Fallopian Tube Neoplasms 15Sarcoma 13Bile Duct Neoplasms 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Hodgkin Disease 10Lymphoma 9Uterine Cervical Neoplasms 8Adenocarcinoma 8Stomach Neoplasms 7Lymphoma, Non-Hodgkin 7Endometrial Neoplasms 7Nasopharyngeal Neoplasms 6

Interventions

Injections 5tislelizumab 2Paclitaxel 2Cisplatin 2Capecitabine 2Bevacizumab 2Pemetrexed 1Oxaliplatin 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumour × Gemcitabine × 1 year × Clear all
NCT07111546 2026-05-26

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
140 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡